Overall, the dietary administration of AhR ligands is a promising strategy for the management of autoimmune diseases since it positively influences the cytokine microenvironment (35) and the phenotype of dendritic (24), T helper (33), and B cells (34). The gene discussed is AHR; the disease is autoimmune disease.